Ongoing research and clinical trials on tissue plasminogen activator helps doctors continue to develop safer procedures and more effective treatment. The Florida Hospital Neuroscience Institute Clinical Research Division studies the affects of tPA to continue to test the safety and effectiveness of the treatment.
Studies also help expand the use of this treatment to patients with other conditions caused by blood clots. With voluntary participation from qualified patients, Florida Hospital seeks more information to develop better treatments.
Learn more about our clinical trials and research.